Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T
Department of Geriatric Medicine, Osaka University Medical School, Suita, Japan.
Diabetologia. 1998 Jan;41(1):47-53. doi: 10.1007/s001250050865.
An insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme (ACE) gene has repeatedly been shown to be associated with ischaemic heart disease, but the association of this genetic marker with diabetic microangiopathy is controversial. To assess the association of the genotypes with the development of diabetic nephropathy or retinopathy, we performed a meta-analysis of data from the literature, using Mantel-Haenszel method followed by the Breslow-Day test for assessing homogeneity among data. In a total of 4773 diabetic patients from 18 studies with (n = 2495) and without (n = 2278) renal complications, the D allele was significantly associated with diabetic nephropathy (p < 0.0001) in a dominant model (summary odds ratio 1.32, 95% confidence interval: 1.15 to 1.51). There was no significant evidence against homogeneity of the odds ratios (chi(2) = 18.9, 20 df; p = 0.53). The association was significant both in non-insulin-dependent (p < 0.005) and in insulin-dependent diabetes mellitus (p < 0.05). Likewise, in a total of 2010 diabetic patients with (n = 1008) and without (n = 1002) retinopathy, there was no association of the I/D polymorphism with diabetic retinopathy. These data suggest that the ACE I/D polymorphism affects the risk for diabetic nephropathy, but not for diabetic retinopathy.
血管紧张素转换酶(ACE)基因中的插入/缺失(I/D)多态性反复被证明与缺血性心脏病有关,但这种基因标记与糖尿病微血管病变的关联存在争议。为了评估这些基因型与糖尿病肾病或视网膜病变发生之间的关联,我们对文献数据进行了荟萃分析,采用Mantel-Haenszel方法,随后进行Breslow-Day检验以评估数据间的同质性。在来自18项研究的总共4773例糖尿病患者中,有肾脏并发症的患者(n = 2495)和无肾脏并发症的患者(n = 2278),在显性模型中,D等位基因与糖尿病肾病显著相关(p < 0.0001)(汇总比值比为1.32,95%置信区间:1.15至1.51)。没有显著证据表明比值比存在异质性(卡方 = 18.9,自由度为20;p = 0.53)。在非胰岛素依赖型糖尿病(p < 0.005)和胰岛素依赖型糖尿病(p < 0.05)中,这种关联均显著。同样,在总共2010例有视网膜病变(n = 1008)和无视网膜病变(n = 1002)的糖尿病患者中,I/D多态性与糖尿病视网膜病变无关联。这些数据表明,ACE I/D多态性影响糖尿病肾病的风险,但不影响糖尿病视网膜病变的风险。